VERYL HODGES

Allopathic & Osteopathic Physicians|Internal Medicine JONESBORO, AR NPI 1013903269

General Payments — all program years on this page

$11,048.51

  • Category: General Payments
  • Program years: PY2018–2024
  • Record count: 866
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $266.05 across 19 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $266.0519

By paying entity

Latest program year (PY2024) · sorted by reported total.

Paying entityAmountRecords
ABBVIE INC. $144.3311
Lundbeck LLC $34.612
PFIZER INC. $26.522
Astellas Pharma US Inc $16.981
GlaxoSmithKline, LLC. $16.031
Sumitomo Pharma America, Inc. $14.101
Lilly USA, LLC $13.481

By program year

Program yearAmountRecords
2018 $3,251.12268
2019 $3,224.40289
2020 $1,659.86118
2021 $2,124.78139
2022 $142.4210
2023 $379.8823
2024 $266.0519

Records — PY2024 (19)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1103926238 ABBVIE INC. $11.43 02/09/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1103926240 ABBVIE INC. $6.85 05/02/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1103926242 ABBVIE INC. $9.53 06/20/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1103926244 ABBVIE INC. $8.01 07/11/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1103926246 ABBVIE INC. $28.61 07/31/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1103926248 ABBVIE INC. $9.68 08/21/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1103926250 ABBVIE INC. $31.07 09/18/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1103926252 ABBVIE INC. $10.84 09/27/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1103926254 ABBVIE INC. $10.54 10/16/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1103926256 ABBVIE INC. $7.91 10/22/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1103926258 ABBVIE INC. $9.86 11/05/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1116649925 GlaxoSmithKline, LLC. $16.03 09/30/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1131837754 PFIZER INC. $13.26 08/15/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1131937271 PFIZER INC. $13.26 09/17/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1135471561 Lilly USA, LLC $13.48 11/19/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1139297072 Astellas Pharma US Inc $16.98 03/19/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1145925496 Lundbeck LLC $18.39 02/07/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1145925498 Lundbeck LLC $16.22 03/04/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1148865127 Sumitomo Pharma America, Inc. $14.10 06/10/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.